title: A point mutation in VP1 of coxsackievirus B4 alters antigenicity.
abstract: While coxsackievirus infections have been linked to several autoimmune diseases, very little is known about the immunogenicity of the coxsackieviruses. Using two genetically related variants of coxsackievirus B4, CB4-P and CB4-V, the relationship between virulence and antigenicity was examined. The virulent variant, CB4-V, was shown to be more antigenic than the avirulent CB4-P variant. The increased antigenicity of CB4-V was due to a single amino acid substitution in the VP1 capsid protein (a threonine residue at amino acid position 129), a site that had been previously identified as a major determinant of viral virulence. Thr-129 of VP1 is predicted to lie within a conformational B cell epitope. In addition, a nearby linear B cell epitope spanning residues 68 to 82 of VP1 was identified as a potential serotype-specific, neutralization antigenic site. The linear and conformational B cell epitopes of coxsackievirus B4 may be analogous to antigenic sites 1 and 1B of poliovirus. To address whether the increased antigenicity of CB4-V influenced the severity of disease, mouse strains that differ in their outcome to viral infection were analyzed. Mice that developed the most severe disease and succumbed to infection were more immunoresponsive than mice that survived infection with CB4-V. The data suggest that immune-mediated mechanisms play a role in the severity of CB4-V induced disease.
authors.affiliation: Department of Biomedical Sciences, School of Public Health, Albany, NY 12237, USA.
authors.forename: S
authors.initials: S
authors.lastname: Halim
authors.forename: A I
authors.initials: AI
authors.lastname: Ramsingh
mesh_terms: D000595:Amino Acid Sequence; D019943:Amino Acid Substitution / Q000235:genetics; D000818:Animals; D000956:Antigens, Viral / Q000737:chemistry / Q000235:genetics / Q000276:immunology*; D002213:Capsid / Q000737:chemistry / Q000235:genetics* / Q000276:immunology*; D003384:Coxsackievirus Infections / Q000276:immunology / Q000401:mortality / Q000821:virology; D029822:Enterovirus B, Human / Q000737:chemistry / Q000235:genetics / Q000276:immunology* / Q000472:pathogenicity*; D018985:Epitopes, B-Lymphocyte / Q000737:chemistry / Q000235:genetics / Q000276:immunology; D014644:Genetic Variation / Q000235:genetics; D007074:Immunoglobulin G / Q000276:immunology; D051379:Mice; D020297:Mice, Congenic; D008815:Mice, Inbred Strains; D008958:Models, Molecular; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000737:chemistry / Q000235:genetics / Q000276:immunology; D017354:Point Mutation / Q000235:genetics*; D011487:Protein Conformation; D016415:Sequence Alignment; D013912:Threonine / Q000235:genetics / Q000276:immunology; D014774:Virulence / Q000276:immunology
chemical_list: D000956:Antigens, Viral; D018985:Epitopes, B-Lymphocyte; D007074:Immunoglobulin G; D010446:Peptide Fragments; D013912:Threonine